139 related articles for article (PubMed ID: 21302626)
1. Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma.
Ballardini P; Marri I; Margutti G; Aliberti C; Benea G; Manfredini R
Tumori; 2010; 96(5):768-70. PubMed ID: 21302626
[TBL] [Abstract][Full Text] [Related]
2. Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study.
Brandi G; de Rosa F; Agostini V; di Girolamo S; Andreone P; Bolondi L; Serra C; Sama C; Golfieri R; Gramenzi A; Cucchetti A; Pinna AD; Trevisani F; Biasco G;
Oncologist; 2013; 18(12):1256-7. PubMed ID: 24232581
[TBL] [Abstract][Full Text] [Related]
3. Durable complete response of hepatocellular carcinoma after metronomic capecitabine.
Brandi G; de Rosa F; Bolondi L; Agostini V; Di Girolamo S; Nobili E; Biasco G
Tumori; 2010; 96(6):1028-30. PubMed ID: 21388070
[TBL] [Abstract][Full Text] [Related]
4. The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
Brandi G; Di Federico A; Rizzo A; De Lorenzo S; Vasuri F; Brocchi S; Golfieri R; Morelli MC; Frega G; Palloni A
Anticancer Drugs; 2022 Jan; 33(1):e781-e783. PubMed ID: 34407053
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine for treatment of advanced hepatocellular carcinoma.
von Delius S; Lersch C; Mayr M; Stock K; Schulte-Frohlinde E; Schmid RM; Eckel F
Hepatogastroenterology; 2007 Dec; 54(80):2310-4. PubMed ID: 18265654
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma.
Abdel-Rahman O; Abdel-Wahab M; Shaker M; Abdel-Wahab S; Elbassiony M; Ellithy M
Med Oncol; 2013; 30(3):655. PubMed ID: 23824645
[TBL] [Abstract][Full Text] [Related]
7. Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases.
Brandi G; Venturi M; De Lorenzo S; Garuti F; Frega G; Palloni A; Garajovà I; Abbati F; Saccoccio G; Golfieri R; Pantaleo MA; Barbera MA
Cancer Commun (Lond); 2018 Jun; 38(1):41. PubMed ID: 29941039
[TBL] [Abstract][Full Text] [Related]
8. Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
McIntosh A; Hagspiel KD; Al-Osaimi AM; Northup P; Caldwell S; Berg C; Angle JF; Argo C; Weiss G; Rich TA
Cancer; 2009 Nov; 115(21):5117-25. PubMed ID: 19642177
[TBL] [Abstract][Full Text] [Related]
9. Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma.
Ang SF; Tan SH; Toh HC; Poon DY; Ong SY; Foo KF; Choo SP
Am J Clin Oncol; 2012 Jun; 35(3):222-7. PubMed ID: 21378539
[TBL] [Abstract][Full Text] [Related]
10. Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.
Goyal R; Chalamalasetty SB; Madan K; Paul SB; Arora R; Safaya R; Acharya SK
Indian J Gastroenterol; 2007; 26(6):292-3. PubMed ID: 18431015
[TBL] [Abstract][Full Text] [Related]
11. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.
Ravaioli M; Cucchetti A; Pinna AD; De Pace V; Neri F; Barbera MA; Maroni L; Frega G; Palloni A; De Lorenzo S; Ripoli MC; Pantaleo MA; Cescon M; Del Gaudio M; Brandi G
Sci Rep; 2017 Sep; 7(1):11305. PubMed ID: 28900245
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.
Dhooge M; Coriat R; Mir O; Perkins G; Brezault C; Boudou-Rouquette P; Goldwasser F; Chaussade S
Oncology; 2013; 84(1):32-8. PubMed ID: 23076239
[TBL] [Abstract][Full Text] [Related]
13. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
[TBL] [Abstract][Full Text] [Related]
14. Safety of capecitabine use in patients with liver dysfunction.
Saif MW; Tejani MA
Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413
[No Abstract] [Full Text] [Related]
15. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.
Coriat R; Mir O; Cessot A; Brezault C; Ropert S; Durand JP; Cacheux W; Chaussade S; Goldwasser F
Invest New Drugs; 2012 Feb; 30(1):376-81. PubMed ID: 20798975
[TBL] [Abstract][Full Text] [Related]
17. Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma.
Park SH; Lee Y; Han SH; Kwon SY; Kwon OS; Kim SS; Kim JH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
BMC Cancer; 2006 Jan; 6():3. PubMed ID: 16396674
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine in advanced hepatocellular carcinoma: A multicenter experience.
Pelizzaro F; Sammarco A; Dadduzio V; Pastorelli D; Giovanis P; Soldà C; Rizzato MD; Lombardi G; Lonardi S; Peserico G; Imondi A; Sartori A; Maddalo G; Farinati F
Dig Liver Dis; 2019 Dec; 51(12):1713-1719. PubMed ID: 31320302
[TBL] [Abstract][Full Text] [Related]
20. Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20.
Patt Y; Rojas-Hernandez C; Fekrazad HM; Bansal P; Lee FC
Oncologist; 2017 Oct; 22(10):1158-e116. PubMed ID: 28687627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]